Unlock stock picks and a broker-level newsfeed that powers Wall Street.
OTC Markets OTCPK - Delayed Quote USD

Suzuken Co., Ltd. (SZUKF)

Compare
30.30
0.00
(0.00%)
At close: April 4 at 4:00:00 PM EDT

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Shigeru Asano President, CEO & Director -- -- 1966
Toyoaki Ota Senior Executive Officer & General Manager of Human Resources and General Affairs Division -- -- --
Mr. Hirofumi Tanaka Executive MD, Senior GM of Healthcare Distribution Business Headquarters & Director -- -- 1963
Ms. Chie Takahashi Sr. Exec. Offr, Sr. GM of Healthcaresolutions Business, GM Solu Busi Plan. Dept & Director -- -- 1967
Yoshihiro Otsuka Senior Executive Officer & Head of the Pharmacy Division -- -- --
Yuichi Yamamoto Executive Officer, Group Planning Division Chief & Corporate Planning Department Chief -- -- --
Mr. Hisashi Tamura Director -- -- 1960

Suzuken Co., Ltd.

8 Higashi Kataha-machi
Higashi-ku
Nagoya, 461-8701
Japan
81 52 961 2331 https://www.suzuken.co.jp
Sector: 
Healthcare
Full Time Employees: 
13,086

Description

Suzuken Co., Ltd., together with its subsidiaries, primarily engages in the distribution of pharmaceuticals in Japan and internationally. The company operates in four segments: Pharmaceutical Distribution, Pharmaceutical Manufacturing, Pharmacy, and Healthcare-Related Services. The Pharmaceutical Distribution Business segment is involved in the purchase and sale of ethical drugs, pharmaceuticals, diagnostic reagents, and medical equipment and supplies to medical institutions and insurance pharmacies. The Pharmaceutical Manufacturing Business segment engages in the research and development, manufacturing, and marketing of ethical pharmaceuticals, and diagnostic reagents focusing on the areas of diabetes and kidney diseases. The Pharmacy Business segment is involved in the medication instruction and drug management for in-home patients, as well as improves the operations of local pharmacies and provides educational support. The Healthcare-Related Services Business segment delivers drugs; provides nursing care services; manufactures, sells, and leases nursing care and medical equipment, such as electrocardiographs, blood pressure monitors, and stethoscopes under Kenz brand name; distributes orphan drugs; develops and operates a product control system for medical materials; sells food products and fixtures and fittings; and develops, manages, and maintains healthcare platforms. This segment also engages in publication and PR activities in the field of medical care and health; and insurance agency business, as well as provides remote image diagnostic support services. In addition, it engages in pharmaceutical logistics business. Suzuken Co., Ltd. was founded in 1932 and is headquartered in Nagoya, Japan.

Corporate Governance

Suzuken Co., Ltd.’s ISS Governance QualityScore as of April 1, 2025 is 7. The pillar scores are Audit: 4; Board: 4; Shareholder Rights: 8; Compensation: 5.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 12, 2025 at 6:00 AM UTC - May 16, 2025 at 6:00 AM UTC

Suzuken Co., Ltd. Earnings Date

Recent Events

March 28, 2025 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers